Compounds > 4-iodo-2,5-dimethoxyphenylisopropylamine
Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Breast Neoplasms

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Breast Neoplasms in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonier, B1
Arseneault, M1
Lavigne, C1
Ouellette, RJ1
Vaillancourt, C1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Breast Neoplasms

ArticleYear
The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin.
    Biochemical and biophysical research communications, 2006, May-19, Volume: 343, Issue:4

    Topics: Amphetamines; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Female; Fluores

2006